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Chlamydia pneumoniae is an important human respira-
tory pathogen that is responsible for an estimated 10% of
community-acquired pneumonia and 5% of bronchitis
and sinusitis cases. We examined changes in global pro-
tein expression profiles associated with the redifferentia-
tion of reticulate body (RB) to elementary body (EB) as C.
pneumoniae cells progressed from 24 to 48 h postinfec-
tion in HEp2 cells. Proteins corresponding to those show-
ing the greatest changes in abundance in the beginning of
the RB to EB transition were then identified from purified
EBs. Among the 300 spots recognized, 35 proteins that
were expressed at sufficiently high levels were identified
by mass spectrometry. We identified C. pneumoniae pro-
teins that showed more than 2-fold increases in abun-
dance in the early stages of RB to EB transition, including
several associated with amino acid and cofactor biosyn-
thesis (Ndk, TrxA, Adk, PyrH, and BirA), maintenance of
cytoplasmic protein function (GroEL/ES, DnaK, DksA,
GrpE, HtrA, ClpP, ClpB, and Map), modification of the
bacterial cell surface (CrpA, OmpA, and OmcB), energy
metabolism (Tal and Pyk), and the putative transcriptional
regulator TctD. This study identified C. pneumoniae pro-
teins involved in the process of redifferentiation into ma-
ture, infective EBs and indicates bacterial metabolic path-
ways that may be involved in this transition. The proteins
involved in RB to EB transition are key to C. pneumoniae
infection and are perhaps suitable targets for therapeutic
intervention. Molecular & Cellular Proteomics 5:
2311–2318, 2006.
Chlamydia pneumoniae causes both acute and chronic hu-
man respiratory disease (1) and has been associated with the
chronic inflammatory process important in atherosclerosis
(2–4). This Gram-negative obligate intracellular pathogen has
a distinct biphasic developmental cycle that is unique to
Chlamydia. Infections initiate when the extracellular infectious
elementary body (EB)1 enters host epithelial cells by endocy-
tosis. In the intracellular vacuole formed, or inclusion, the EB
differentiates into a metabolically active reticulate body (RB)
over the first 9 h and begins to replicate by binary fission by
19 h (5). RBs subsequently begin to redifferentiate into EBs,
which are first detectable at 48 h and released by host cell
lysis at 60–84 h postinfection (hpi) (5, 6). Formation and
release of EBs is necessary to initiate new cycles of infection.
Although the temporal aspects and morphological progress
of the C. pneumoniae developmental cycle have been char-
acterized by microscopy (5, 6), the associated changes in
cellular composition, metabolic activities, and regulatory
mechanisms constituting this infection cycle remain largely
unknown. Information from the C. pneumoniae genome se-
quence (7, 8) and studies of C. trachomatis using whole-
genome gene expression profiling (9, 10) indicate that C.
pneumoniae likely also relies on coordinated regulation of a
specific set of genes to achieve its efficient biphasic infection
cycle. Defining these stages and the associated microbial
factors is now possible using powerful new genetic and bio-
chemical analysis methods.
To better understand and identify microbial factors associ-
ated with the initial stages of C. pneumoniae transition from
an intracellular replicating RB into an infectious EB under
normal ´ growth conditions, we used a global protein analysis
approach based on two-dimensional electrophoresis, com-
puter image analysis, and identification of bacterial proteins
by mass spectrometry. We were able to detect substantial
reproducible differences in protein expression profiles from 24
to 48 hpi and to identify 35 differentially expressed proteins
that could be obtained in sufficient quantities from fully dif-
ferentiated EBs. The majority of these proteins are predicted
to be involved in translation and protein metabolism from
studies of other bacterial species. Others included a poten-
tially important putative transcriptional regulator and several
that are likely associated with cell wall remodeling that occurs
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EXPERIMENTAL PROCEDURES
Cell Cultures—HEp2 cells (ATCC CCL-23) were obtained from the
American Type Culture Collection (ATCC, Manassas, VA) and main-
tained in Iscove’s maintenance medium (Cellgro, Washington, D. C.)
as described previously (11). Cells were grown in 75-cm2 flasks
(Costar, Cambridge, MA) at 37 °C in 5% CO2 for 24 h to achieve
confluency of the monolayer and harvested with trypsin-EDTA.
Bacterial Cultures—C. pneumoniae A-03 (ATCC VR-1452) was pre-
viously isolated from a coronary atheroma of a patient undergoing
heart transplantation surgery at the Jewish Hospital Heart and Lung
Institute, Louisville, KY (3). C. pneumoniae were propagated in HEp2
cell monolayers in Iscove’s growth medium. EBs were harvested at
72 h and purified by disruption of HEp2 cell monolayers with a cell
scraper, sonication, and centrifugation over a Renografin density
gradient as described previously (11). EB suspensions in sucrose-
phosphate-glutamic acid buffer were stored at 80 °C.
Cell Culture Infections—HEp-2 cells were seeded in 6-well plates at
0.5  106 cells/well in Iscove’s maintenance medium and incubated in
5% CO2 at 37 °C overnight. Cells were subsequently inoculated with
0.5 108 inclusion-forming units/well (multiplicity of infection, 100:1) of
C. pneumoniae in 2 ml of Iscove’s growth medium, centrifuged at 675
g for 1 h at 10 °C, and incubated at 37 °C in 5% CO2 for 24 h.
Transmission Electron Microscope (TEM) Analysis—TEM was used
to visualize C. pneumoniae interactions with host cells by analyzing
the cell cultures as follows. Specimens were fixed with 3% glutaral-
dehyde (Sigma) fixative in 0.1 M phosphate buffer at pH 7.4. After
fixation for 1 h at room temperature, cells were scraped off, washed
in 0.1 M phosphate buffer, postfixed in 1% osmium tetroxide, and
embedded in Spurr epoxy resin according to standard procedures
(12). Ultrathin sections (50–100 nm) were cut and stained with uranyl
acetate and lead citrate stains and examined with a JEOL 1200EX
transmission electron microscope.
Protein Labeling—For global analysis of bacterial proteins, infected
HEp-2 cells were pulse-labeled for 2 h (at 22 and 46 hpi, respectively)
in methionine/cysteine-free RPMI 1640 medium (Cellgro, Herndon,
VA) containing 100 Ci of [35S]methionine/cysteine (Redivue Pro-
Mix)/ml (Amersham Biosciences) and 500 g of cycloheximide/ml. At
the end of the 2-h labeling period, HEp-2 cells were washed in cold
phosphate-buffered saline, scraped with a cell scraper, and pelleted
by centrifugation at 16,000  g.
Protein Extraction—C. pneumoniae-infected HEp-2 cell pellets
were resuspended in 30 l of buffer containing 2% (w/v) Sarkosyl, 1%
(w/v) octyl -D-1-thioglucopyranoside, 2 mM tributylphosphine, and 5
l of protease inhibitors (leupeptin and aprotinin). Samples were
sonicated (cell dismembrator, Model 100, Fisher Scientific) for 5 s,
boiled for 5 min, and then cooled to room temperature. One hundred
microliters of thiourea lysis buffer (7 M urea, 2 M thiourea, 10 mM Tris,
2 mM tributylphosphine, and 2% (v/v) Ampholine) were added fol-
lowed by the addition of 3.0 l of a mixture of 50 mM MgCl2, 476 mM
Tris-HCl, 24 mM Tris base, 1.0 mg of DNase-1/ml, and 0.250 mg of
RNase A/ml (pH 8.0); kept on ice for 10 min; and stored at 80 °C.
Two-dimensional Gel Electrophoresis—For generating electro-
phoretic protein maps of purified C. pneumoniae EB suspension, 750
g of protein extracts were first mixed with an IPG rehydration buffer
as mentioned previously (13). Briefly for intracellular C. pneumoniae
protein expression studies, 75 g of 35S-labeled chlamydial proteins
were mixed in IPG rehydration buffer and loaded onto IPG strips
(Bio-Rad ReadyStripTM IPG strip; strip length, 17 cm), allowed to
rehydrate overnight, and isoelectrofocused in a PROTEAN IEF cell
(Bio-Rad). A rapid advance voltage ramping method was applied as
mentioned previously (13). After focusing was completed, IPG strips
were equilibrated in equilibration base buffer with 2% (w/v) dithiothre-
itol followed by another equilibration step with 2.5% (w/v) iodoacet-
amide. The second dimension was carried out with polyacrylamide
gel electrophoresis (10% polyacrylamide formulated in Tris-HCl) on
19.3 cm  18.3 cm  1.0 mm slab gels (PROTEAN II precast ready
gel) in a PROTEAN II xi multicell system (Bio-Rad) at 4 °C for 3.5 h
under a 500-V maximum voltage with 1 Tris-Tricine-SDS buffer
used as the upper electrode buffer and 1 Tris-glycine-SDS used as
lower electrode buffer (Bio-Rad). Gels containing purified EB proteins
were silver-stained, whereas gels containing radiolabeled chlamydial
proteins were fixed in a solution containing 40% ethanol and 7.5%
acetic acid for 30 min and treated with Amplify fluorographic reagent
(Amersham Biosciences) for 30 min, vacuum-dried, and exposed to
high density phosphorimaging screens (Bio-Rad Inc.) for 2.5 days.
Images were scanned in a Molecular Imager FX Pro PlusTM system
(Bio-Rad).
Image Analysis—Protein spots were analyzed and quantified for
differential expression patterns using PDQuestTM software version 7.1
(Bio-Rad), which interfaced directly with the PhosphorImager using
ProteomeWorks software. Protein spots on different gels were
aligned by the pattern recognition feature of the software. PDQuest
software was also used for quantification in which pixel values for
each identified spot were first normalized as a percentage of total
pixel quantity of all valid spots for each individual gel image. After
normalization, analytical tools in PDQuest software were used for
statistical analysis of differential expression patterns.
Identification of Protein Spots—Spots of interest from the 35S-
labeled gels were then matched with images of up to 10-silver stained
C. pneumoniae 72-h EB gels with PDQuest, and corresponding spots
were excised from the silver-stained gels and treated with 20 g of
trypsin/ml in 50 mM ammonium bicarbonate at 37 °C overnight. For
those proteins that appeared in “tracts,” multiple samples were col-
lected to ensure they corresponded to a single protein. Two micro-
liters of supernatant were mixed in an equal volume of saturated
-cyano-4-hydroxycinnamic acid, 50% (v/v) acetonitrile, 0.1% (v/v)
trifluoroacetic acid, and 0.8 l of the resulting solution was applied to
the MALDI-MS template. Masses of peptide fragments were deter-
mined by MALDI-TOF analysis with a Micromass mass spectrometer.
Patterns of measured masses were matched against theoretical
masses and pI values of proteins found in the annotated National
Center for Biotechnology (NCBI), Swiss-Prot, and TrEMBL databases
accessible in the ExPASy Molecular Biology server (expasy.cbr.n-
rc.ca/). Searches were performed with ProFound-Peptide Mapping
software (The Rockefeller University Edition version 4.10.5) with re-
strictions to proteins from 1 to 100 kDa and mass tolerances of
100–150 ppm. Partial enzymatic cleavages leaving one cleavage site,
oxidation of methionine, and modification of cysteine with iodoacet-
amide were considered in these searches. Sequence coverage45%
(p value 0.05) was considered as a positive match.
Quantitative PCR—RNA was isolated using TRIzol (Invitrogen) from
24- and 48-hpi C. pneumoniae-infected HEp-2 monolayers that were
cultured in duplicate according to the method described by Hogan et
al. (14). Contaminating DNA was removed by incubation with 40 units
of RNase-free DNase and RNase inhibitor (Roche Applied Science) at
37 °C for 1 h followed by precipitation with ammonium acetate and
ethanol and several 70% ethanol washes. The RNA was resuspended
in 50 l of diethyl pyrocarbonate-treated double distilled H2O. The
absence of genomic DNA was confirmed by 16 S PCR as described
previously (15).
cDNA was generated from 1 g of total RNA as described previ-
ously (14) except that the random hexamers (1 g) were incubated
with the RNA at 65 °C for 10 min before the addition of 12 units of
RNase inhibitor and 50 units of Expand reverse transcriptase (Roche
Applied Science) in 1 Expand buffer in a 20-l reaction. The reaction
mixture was incubated at 30 °C for 10 min followed by 42 °C for 45
min. Residual RNA was removed, and cDNA was purified as de-
scribed previously (14) before storage at 20 °C.
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Primers (Table I) for quantitative PCR were designed for the 35
genes for proteins identified as differentially expressed (Primer-
Express 2.0, Applied Biosystems, Melbourne, Australia). Standard
controls for each primer pair were generated by amplifying C. pneu-
moniae genomic DNA followed by purification via QIAquick columns
(Qiagen, Victoria, Australia). The cDNA was quantitated using the ABI
Prism 7000 (Applied Biosystems) in a standard reaction containing
1.0 l of cDNA in a final concentration of 1 ABI SYBR green Master
Mix (Applied Biosystems) and a 10 M concentration of each primer
(forward and reverse, Table I) in a final volume of 25 l. Cycling
parameters for all reactions were: 95 °C for 10 min followed by 40
cycles of 95 °C for 15 s and 1 min of annealing and extension at 60 °C
with melting curve analysis from 60 to 95 °C with data acquisition
every 1 °C. Standard curves were generated for each gene using 103,
105, 107, and 109 copies of each standard, and negative controls were
performed for each gene. All reactions were performed in triplicate
using the standard reaction mixture and cycling conditions as de-
scribed above. ABI Prism 7000 SDS Software version 1.0 (Applied
Biosystems) was used to analyze amplification curves for each cDNA
and determine the copy number. Grubb’s test was used to identify
outlying copy numbers that were subsequently excluded from further
calculations. Data are presented as the mean cDNA copy number
obtained for each gene divided by the corresponding mean 16 S
cDNA values.
TABLE I
Primers for individual genes used in this study
C. pneumoniae CWL029 sequence (GenBankTM accession number AE001363) was used to design the primers.
C. pneumoniae Proteins in EB Formation
Molecular & Cellular Proteomics 5.12 2313
RESULTS
Ultrastructural Analysis of C. pneumoniae Development—
Similar to that which has been described previously for HeLa
cells (5), C. pneumonia EBs were internalized by HEp2 cells
and by 24 h showed complete differentiation into larger rep-
licating RBs by TEM examination (Fig. 1A). RBs were ob-
served throughout the entire inclusion. By 48 h postinfection,
the transition to EBs had begun (Fig. 1B) with 50% of C.
pneumoniae showing characteristic reduced size and con-
densed nucleoid structure. We could also identify intermedi-
ate transitional forms as cell differentiation had become asyn-
chronous by 48 h. We therefore chose to compare protein
expression at 24 and 48 h to identify those bacterial proteins
that contribute in the initial stages of the developmental tran-
sition from RB to infectious EBs.
Temporal Analysis of C. pneumoniae Protein Expression in
Infected HEp2 Cells—To examine expression of chlamydial
proteins at 24 and 48 h postinfection, infected HEp2 cells
were pulse-labeled for 2 h with [35S]methionine/cysteine in the
presence of cycloheximide at either 22 or 46 h. Total protein
extracts were prepared from lysed monolayers, and the ra-
diolabeled bacterial proteins were analyzed by two-dimen-
sional gel electrophoresis. Fig. 2 shows two representative
PhosphorImager scans of gels showing proteins resolved
among those expressed by C. pneumoniae at 24 and 48 h.
More than 300 protein spots could be detected in pH 3–11
FIG. 2. Two-dimensional electrophoretic map ofC. pneumoniae proteins expressed at 24 and 48 hpi in HEp2 cells. Representative gels
of 10 experiments are shown. A summary of the -fold changes is listed in Tables II and III.
FIG. 1. Transmission electron micro-
graph indicating morphological fea-
tures of C. pneumoniae grown in
HEp2 cells showing typical RBs and
an absence of EBs at 24 hpi (A) and
typical EBs and RBs at 48 hpi (B), con-
firming asynchronous developmental
cycle due to redifferentiation of RBs
to EBs.
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range with a combination of IPG strips pI 4–7, 6–11, and
3–10. Gels were then matched with 6–10 independent silver-
stained gels that were used to separate larger amounts of
unlabeled proteins from purified EB preparations. This proce-
dure was necessary to obtain sufficient material for protein
identification by MALDI-MS. Each mapped protein spot (Fig.
2) was quantified in terms of a percentage of the sum of all
radioactive spots detected on the same gel to allow compar-
ison of gels showing differences in overall image intensity. A
subset of those proteins that showed the greatest differential
expression at 24 and 48 h for which we were able to obtain
sufficient protein sample from silver-stained gels (n  35)
were then characterized by MALDI-TOF-MS. A summary of
these analyses is presented in Table II.
We considered a threshold of 2-fold as a significant change
in protein level based on previous studies (9, 16, 17). Thirty-
one of the 35 proteins (89%) identified to be temporally cor-
related with the initial steps in the morphological redifferenti-
TABLE II
Expression profiles of C. pneumoniae proteins at 48 versus 24 hpi
The differential regulation pattern at 48 hpi was compared with respect to 24 hpi. The 24-hpi sample was considered as 1-fold. More than
2.0-fold change was considered significant. Proteins have been grouped together according to functional assignments provided at www.
gram.au.dk/Cpn_table_link.html. OMP, outer membrane protein.
Functional assignments Function Expression profile
Biosynthesis of amino acids and cofactors
Ndk Nucleoside-2-phosphate kinase Present (up)a
TrxA Thioredoxin 4.5 (down)
Adk Adenylate kinase 14.8 (up)
PyrH UMP kinase 2.1 (up)
BirA Biotin synthase Present (up)a
Cell envelope
CrpA 15-kDa cystine-rich protein 6.5 (up)
OmpA Outer membrane protein Present (up)a
OmcB Cystine-rich OMP 3.3 (up)
Cellular processes
AhpC Alkyl hydroperoxide reductase 6.2 (up)
GspD General secretion protein D 4.6 (down)
Energy metabolism
Tal Transaldolase 5.4 (up)
Pyk Pyruvate kinase 4.9 (up)
Protein folding, assembly, and modification
GroEL_1 Heat shock protein-60 6.4 (up)
GroES Heat shock protein-10 3.3 (up)
DnaK Heat shock protein-70 5.0 (up)
DksA DnaK suppressor 1.9 (up)
GrpE HSP-70 cofactor 3.1 (up)
HtrA DO serine protease 14.7 (up)
ClpP_1 Endopeptidase Clp1 5.2 (up)
ClpB Clp protease ATPase 11.6 (up)
Transcription
GreA Transcription elongation factor 9.3 (up)
RpoA RNA polymerase  chain 7.3 (up)
TctD Transcription regulatory protein 5.6 (up)
Translation
Map Methionine aminopeptidase 8.7 (up)
Tsf Elongation factor TS 9.0 (up)
TufA Elongation factor TU 7.1 (up)
Efp1 Elongation factor P1 2.9 (up)
PfrA Peptide chain release factor-1 4.8 (up)
RpIL (R17) 50 S ribosomal protein L7/L12 4.5 (up)









a Present in 48 hpi only, 10-fold.
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ation from RBs into infectious EBs showed increased
expression, whereas only four proteins (11%) identified were
found to decrease with the onset of bacterial redifferentiation
(Table II). We likely identified more proteins whose expression
increased as we were only able to identify proteins whose
expression remained at sufficient levels for MALDI-TOF-MS
analysis in purified EBs prepared at a later time point (see
“Experimental Procedures”). Among the down-regulated pro-
teins, thioredoxin (TrxA) and general secretion protein D
(GspD) were down-regulated by 4.5- and 4.6-fold, respec-
tively (Table II). Levels of C. pneumoniae hypothetical proteins
CPn0742 and Cpn0216 decreased 2.8- and 2.2-fold,
respectively.
Proteins whose levels showed relatively small increases (up
to 4-fold) as bacteria began differentiation into EBs included
uridine monophosphate kinase (PyrH), the cysteine-rich outer
membrane protein OmcB, heat shock protein-10 (GroES), the
DnaK suppressor DksA, heat shock protein-70 cofactor
(GrpE), translation elongation factor P1 (Efp1), and 30 S ribo-
somal protein S1 (RpsA/Rs1) (Table II). Proteins showing
higher levels of increase (4–6-fold) included transaldolase
(Tal), pyruvate kinase (Pyk), heat shock protein-70 (DnaK),
endopeptidase Clp 1 (ClpP_1), helix-turn-helix transcriptional
regulatory protein (TctD), peptide chain release factor-1 (PfrA),
50 S ribosomal protein L7/L12 (RplL/Rl7), and CPn0917 (hy-
drolase/phosphatase homologue). Seven proteins showed
larger relative increases (6–10-fold); a 15-kDa cysteine-rich
protein (CrpA), alkyl hydroperoxide reductase (AhpC), heat
shock protein 60 kDa (GroEL), methionine aminopeptidase
(Map), transcription elongation factor (GreA), RNA polymerase
 chain (RpoA), elongation factor TS (Tsf), elongation factor
TU (TufA), and hypothetical protein CPn0710. Four proteins
were found to increase more than 10-fold: adenylate kinase
(Adk), DO serine protease (HtrA), Clp protease (ClpB), and
hypothetical protein CPn0518. Ndk, BirA, and OmpA showed
the most dramatic differential expression with detection only
at 48 h.
Temporal Analysis of C. pneumoniae Gene Expression in
Infected HEp2 Cells—Quantitative fluorescence-monitored
RT-PCR was performed for the 35 mRNAs encoding EB pro-
teins identified by MALDI-TOF-MS. 16 S rRNA was used as an
internal standard for comparison of transcript levels at 24 and
48 h as described previously for other chlamydial species (9,
14). These data are summarized in Table III. Only 10 RNAs
showed significant changes (2-fold) in steady state levels at
48 h: crpA (12.4-fold up), dksA (3.2-fold up), CPn0216 (2.7-
fold up), CPn0710 (5.1-fold up), efp1 (3-fold down), tctD (21.6-
fold up), omcB (6.6-fold up), ompA (2.4-fold up), clpB (7.7-fold
up), and CPn0518 (2.8-fold down). The remaining 25 mRNAs
encoding proteins whose levels increased during this initial
stage of morphological differentiation remained unchanged
between 24 and 48 h in these assays. Levels of three tran-
scripts, efp1, CPn0518, and CPn0216, did not correspond to
the respective protein levels. It is likely that the level of post-
transcriptional and post-translational regulation of these
genes plays an important role. However, we were also able to
see obvious increases for a subset of mRNAs in these same
assays (Table III).
DISCUSSION
The developmental cycle of C. pneumoniae in HEp2 cells is
an asynchronous process, resulting in a heterogeneous pop-
ulation of bacterial morphologies at any given time point. In
the experiments described here, we normalized individual
protein expression to the entire population at the 24- and 48-h
time points and determined quantitative changes in expres-
sion levels.
We identified 35 C. pneumoniae proteins from nine func-
tional groups, representing 11.6% of the total proteins ex-
pressed, whose expression levels changed as bacteria began
the secondary differentiation from intracellular replicating RBs
into infectious EBs. Almost one-half of these were bacterial
factors associated with protein metabolism, including pro-
teases, chaperones, and translation factors. Alterations of
ribosome function and cell protein remodeling and turnover
were a central recognizable aspect of the onset of this mor-
phological differentiation. Our analysis of the mRNAs encod-
ing these 35 proteins was also consistent with a model where
post-transcriptional regulatory mechanisms may play a role in
C. pneumoniae differentiation. Although we have not tested
this hypothesis in this study, further studies will be important
to determine these mechanisms and to define transcriptional
regulation involving the TctD transcription factor.
The expression of three cell membrane proteins genes
(crpA, ompA, and omcB) was found to increase at both the
mRNA and protein level as bacteria progressed from 24 to
48 h postinfection. mRNAs encoding these proteins have also
TABLE III










CrpA 12.4 (up) 6.5 (up)
ompA 2.4 (up) Present (up)a
omcB 6.6 (up) 3.3 (up)
Protein folding, assembly
and modification
dksA 3.2 (up) 1.9 (up)
clpB 7.7 (up) 11.6 (up)
Transcription
tctD 21.6 (up) 5.6 (up)
Translation
Efp1 3.0 (down) 2.9 (up)
Hypothetical proteins
Cpn0710 5.1 (up) 8.6 (up)
CPn0518 2.8 (down) 12.8 (up)
CPn0216 2.7 (up) 2.2 (down)
a Present in 48 hpi only, 10-fold.
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been shown to increase in other Chlamydia species as EB
formation begins (9, 10). OmcB is a cysteine-rich outer mem-
brane protein that undergoes post-translational proteolytic
processing (18) and forms a highly disulfide-cross-linked
outer membrane complex with OmpA. CrpA is also a cys-
teine-rich protein whose cross-linking with OmpA, the major
outer membrane protein, may contribute to relative environ-
mental resistance of the EB.
A transaldolase (Tal) and pyruvate kinase (Pyk) were in-
creased in expression as bacteria began redifferentiation into
EBs during HEp2 infection. Both of these proteins have pre-
dicted roles in bacterial energy metabolism. Tal is a rate-
limiting enzyme of the non-oxidative reaction in pentose
phosphate pathway (PPP) (19). Together with transketolase,
Tal provides a link between glycolysis and the PPP. Increased
Tal expression during redifferentiation may allow increased
catabolism of sugars, and the PPP also potentially provides
the cell with intermediates for the synthesis of amino acids,
nucleotides, vitamins, and cell wall constituents (19). In-
creases and some decreases in the levels of other proteins in
biosynthetic pathways were also seen, indicating a realign-
ment of metabolism as bacteria began the active process of
EB formation. For example, the enzyme Pyk catalyzes the final
step in glycolysis by converting phosphoenolpyruvate to
pyruvate with concomitant phosphorylation of ADP to ATP
(20). Both Pyk and Tal have previously been shown to in-
crease during C. trachomatis replication, providing ATP for
metabolism (21, 22).
A final important class of protein whose increased synthesis
was seen upon differentiation into EB were specific to
Chlamydia (Table II), including CPn0216, which shows no
similarity to any protein in any other species. Similarly the
large class of Chlamydia trachomatis genes consisting of
unknown function whose expression was increased with EB
formation are those lacking homologues in other species (10).
These are likely components of the infectious EB that impart
its unique characteristics, including the ability to attach to and
enter a wide variety of host cells.
An important aspect of any natural population of bacteria is
the heterogeneity within as described for the C. pneumoniae
populations at 48 hpi. The presence of RBs, EBs, and transi-
tional forms in this population prevents an entirely accurate
numerical determination of the specific magnitude of differ-
ential gene expression and resulting RNA and protein levels in
individual cells during redifferentiation, and we are only able to
report an average level for all types of cells present in this
population. The specific value given in Table II therefore de-
scribes the relative degree of increased expression and must
be viewed as an estimate. This acknowledged difficulty did
not prevent us from identifying a small core group of proteins
whose levels do increase relative to all detectable cellular
proteins in our assays. These bacterial factors are clearly
important in the process by which C. pneumoniae begins
redifferentiation back into infectious EBs.
Although specific morphological changes in the Chlamydia
life cycle have been carefully described for several decades,
our knowledge of the biochemical nature of this developmen-
tal process remains lacking. Identification of 35 proteins
whose expression levels change as C. pneumoniae differen-
tiates into infectious EBs late in infection contributes impor-
tant initial basic information about this largely uncharacterized
molecular process. Although with this report we have only
begun to describe the participants in this process, we have
identified what are likely to be significant proteins in the EB
formation process that may reveal biomarkers for therapeutic
strategies.
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